Embryos with compound <i>Shroom3</i>^<i>Gt/fl</i> alleles phenocopy <i>Shroom3</i>^<i>Gt/Gt</i> embryos. by Jennifer L. Carleton (22208916)

Subjects:

<i>Shroom3</i> is expressed in the mouse heart during cardiogenesis. by Jennifer L. Carleton (22208916)

Subjects:

Myocardial <i>Shroom3</i> loss during development does not show ventricular septal defects. by Jennifer L. Carleton (22208916)

Subjects:

Additional images of <i>Nkx2–5-Cre;Shroom3</i>^<i>fl/fl</i> neonate semilunar valve morphologies. by Jennifer L. Carleton (22208916)

Subjects:

Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness. by Jennifer L. Carleton (22208916)

Subjects:

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show ventricular septal defects. by Jennifer L. Carleton (22208916)

Subjects:

<i>Shroom3</i> is expressed throughout the mouse myocardium during cardiogenesis. by Jennifer L. Carleton (22208916)

Subjects:

Schematic of <i>Shroom3</i> gene trap allele and novel floxed <i>Shroom3</i> allele. by Jennifer L. Carleton (22208916)

Subjects:

<i>Shroom3</i> is expressed in the postnatal mouse heart. by Jennifer L. Carleton (22208916)

Subjects:

Semi-quantitative PCR for <i>Shroom3</i>^<i>fl</i> recombination and band quantification with densitometry. by Jennifer L. Carleton (22208916)

Subjects:

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show left ventricular thinning. by Jennifer L. Carleton (22208916)

Subjects:

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show abnormal semilunar valves. by Jennifer L. Carleton (22208916)

Subjects:

Adult <i>Shroom3</i>^<i>+</i>^<i>/Gt</i> mouse hearts show left ventricular thinning. by Jennifer L. Carleton (22208916)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years. by Xiaofeng He (2618752)

Subjects: